A surge in the number of satellites in orbit has created new opportunities to monitor environmental and human rights issues, but it also poses serious sustainability challenges. Emissions from launches, orbital debris, and outdated laws are fueling concerns about the sustainability of current outer space activities. Space technology is used for homeland and international security, Earth observation, telecommunications, satellite navigation, scientific exploration, and economic development. We believe we have a responsibility to ensure a sustainable space environment with access to limited orbital slots, resources mined in space, and jobs within the sector.
and reforestation to deliver results that are in line with the UN Sustainable Development Goals. It specializes in giving clients advice on energy efficiency, clean energy options, tr
such as synthetic dyes and parabens, which can be harmful and, in the long run, lead to skin cancer. Our advocacy for sustainable skincare stems from our ethical values. Here comes the role of biotech beauty, which combines biology with technology. By creating ingredients like Epidermal Growth Factor, which cannot be otherwise sourced from nature, the movement is just picking up pace. Sustainable skincare should no longer be an option, but your choice for your own good and that of Mother Earth.
After a year of service, the e-ferry’s operators concluded that the system has a highly sustainable energy efficiency of 85%, almost twice that of diesel boats. With this background, the US$20 billion market expectation for electric watercraft seems more than reasonable. To support this industry, we are following a firm that has designed, and begun delivering, an electric-powered watercraft. Destined for the lucrative leisure market, this is a mere stepping stone to the huge water taxi market for which a design is already complete.
technology that detects one of the deadliest types of cancer and treats it without damaging healthy cells and tissues. Its electromagnetic stimulation, combined with a nanotechnology system, has demonstrated the preclinical treatment to be safe and effective. The medical device has been classified as class III to chronically treat and reduce cancer’s mass significantly from further development. The firm has started Phase I and seeking investments to support this phase. Based on Phase I results, which will be within 12-15 months, they plan an IPO for Phase II, the last one before the commercial launch in North America by 2024.
The firm’s platform matches investors with advanced learners by exploiting the fully scalable and high-return potential of non-loan Income Share Agreements (ISA’s). Investors in ISA’s may finely tune their investment criteria to match their corporate objectives, which may include CSR targets. Currently, the firm is proposing two types of investment opportunity: in the infinite possibilities of direct investments in ISA’s and, more conventionally, investments in shares (and, as the firm is designated by the French state as an innovative firm, offers the possibility of French residency/citizenship).
